Recombinant
plectasin, the first fungus
defensin, was expressed in Pichia pastoris and purified, and its physical, chemical and antimicrobial characteristics were studied. Following a 120 h induction of recombinant yeast, the amount of total secreted
protein reached 748.63 μg/ml. The percentage of recombinant
plectasin was estimated to be 71.79% of the total
protein. After purification with a
Sephadex G-25 column and RP-HPLC, the identity of
plectasin was verified by MALDI-TOF MS.
Plectasin exhibited strong antimicrobial activity against the Gram-positive bacteria Staphyloccocusaureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Streptococcus suis. At a concentration of 2560 μg/ml, this
peptide showed approximately equal activity against S. aureus, S. epidermidis, S. suis, and S. pneumoniae, when compared to 320 μg/ml
vancomycin, 640 μg/ml
penicillin, 320 μg/ml
vancomycin and 160 μg/ml
vancomycin, respectively. In addition,
plectasin showed anti-S. aureus activity over a wide pH range of 2.0 and 10.0, a high thermal stability at 100 °C for 1h and remarkable resistance to
papain and
pepsin. The expression and characterization of recombinant
plectasin in P. pastoris has potential to treat Streptococcus and Staphyloccocus
infections when most traditional
antibiotics show no effect on them. Our results indicate that
plectasin can be produced in large quantities, and that it has
pharmaceutical importance for the prevention and clinical treatment of Staphyloccocus and Streptococcus
infections.